117 related articles for article (PubMed ID: 26460311)
21. Acquired neuromyotonia in thymoma-associated myasthenia gravis: a clinical and serological study.
Gastaldi M; De Rosa A; Maestri M; Zardini E; Scaranzin S; Guida M; Borrelli P; Ferraro OE; Lampasona V; Furlan R; Irani SR; Waters P; Lang B; Vincent A; Marchioni E; Ricciardi R; Franciotta D
Eur J Neurol; 2019 Jul; 26(7):992-999. PubMed ID: 30714278
[TBL] [Abstract][Full Text] [Related]
22. [Association of polymyositis, myasthenia, and thymoma. A case and review of the literature].
Weiller PJ; Durand JM; Prince-Zucchelli MA; Cros D; Pouget J; Pelissier JF; Mongin M
Ann Med Interne (Paris); 1984; 135(4):299-304. PubMed ID: 6476668
[TBL] [Abstract][Full Text] [Related]
23. Thymoma hyalinized by steroid therapy in myasthenia gravis.
Yoshida Y; Ueda R; Murakawa T; Ota S; Nakajima J
Asian Cardiovasc Thorac Ann; 2012 Aug; 20(4):479-81. PubMed ID: 22879563
[TBL] [Abstract][Full Text] [Related]
24. Myasthenia gravis with thymoma and pure red blood cell aplasia.
Bailey RO; Dunn HG; Rubin AM; Ritaccio AL
Am J Clin Pathol; 1988 May; 89(5):687-93. PubMed ID: 3128948
[TBL] [Abstract][Full Text] [Related]
25. Eosinophilia, myositis, and myasthenia gravis associated with a thymoma.
Avni I; Sharabi Y; Sadeh M; Buchman AS
Muscle Nerve; 2006 Aug; 34(2):242-5. PubMed ID: 16506154
[TBL] [Abstract][Full Text] [Related]
26. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
[TBL] [Abstract][Full Text] [Related]
27. [Histological studies of thymomas from 17 myasthenia gravis and 1 pure red cell aplasia patients and the T cell subsets before and after in vitro culture with rIL-2].
Takiguchi T
Arerugi; 1993 May; 42(5):665-75. PubMed ID: 8323466
[TBL] [Abstract][Full Text] [Related]
28. Inflammatory myopathy with myasthenia gravis: Thymoma association and polymyositis pathology.
Uchio N; Taira K; Ikenaga C; Kadoya M; Unuma A; Yoshida K; Nakatani-Enomoto S; Hatanaka Y; Sakurai Y; Shiio Y; Kaida K; Kubota A; Toda T; Shimizu J
Neurol Neuroimmunol Neuroinflamm; 2019 Mar; 6(2):e535. PubMed ID: 30697585
[TBL] [Abstract][Full Text] [Related]
29. Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice.
Spuler S; Sarropoulos A; Marx A; Hohlfeld R; Wekerle H
Am J Pathol; 1996 May; 148(5):1359-65. PubMed ID: 8623907
[TBL] [Abstract][Full Text] [Related]
30. [The clinical characteristics of patients with thymoma-associated myasthenia gravis].
Chen YP; Wang W; Wang ZK; Dou YK; Wei DN
Zhonghua Nei Ke Za Zhi; 2012 Aug; 51(8):623-5. PubMed ID: 23158861
[TBL] [Abstract][Full Text] [Related]
31. Flow cytometric study of lymphocytes associated with thymoma and other thymic tumors.
Fujii Y; Okumura M; Yamamoto S
J Surg Res; 1999 Apr; 82(2):312-8. PubMed ID: 10090845
[TBL] [Abstract][Full Text] [Related]
32. Bilineage hematopoietic inhibitor and T lymphocyte dysfunction in a patient with pure red cell aplasia, myasthenia gravis and thymoma.
Murase T
Exp Hematol; 1993 Mar; 21(3):451-5. PubMed ID: 8440342
[TBL] [Abstract][Full Text] [Related]
33. Response to treatment of myasthenia gravis according to clinical subtype.
Akaishi T; Suzuki Y; Imai T; Tsuda E; Minami N; Nagane Y; Uzawa A; Kawaguchi N; Masuda M; Konno S; Suzuki H; Murai H; Aoki M; Utsugisawa K
BMC Neurol; 2016 Nov; 16(1):225. PubMed ID: 27855632
[TBL] [Abstract][Full Text] [Related]
34. Myasthenia gravis, thymoma and myositis in a dog.
Darke PG; McCullagh KG; Geldart PH
Vet Rec; 1975 Nov; 97(20):392-3. PubMed ID: 1209894
[No Abstract] [Full Text] [Related]
35. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
[TBL] [Abstract][Full Text] [Related]
36. Myasthenia gravis: disease severity and prognosis.
Romi F; Gilhus NE; Aarli JA
Acta Neurol Scand Suppl; 2006; 183():24-5. PubMed ID: 16637923
[TBL] [Abstract][Full Text] [Related]
37. [Serum anti-titin antibody in patients with myasthenia gravis].
Li YF; Zhang JB; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec; 25(6):725-7. PubMed ID: 14714322
[TBL] [Abstract][Full Text] [Related]
38. Neutralizing antibodies against endogenous interferon in myasthenia gravis patients.
Bagnato F; Clemenzi A; Scagnolari C; Strizzi L; Di Pasquale A; Bellomi F; Di Marco P; Antonelli G; Antonini G
Eur Cytokine Netw; 2004; 15(1):24-9. PubMed ID: 15217749
[TBL] [Abstract][Full Text] [Related]
39. [Clinical characteristics and outcome of myasthenia gravis with and without thymoma after operation].
Wang RW; Jiang YG; Xue ZQ; Zhao YP; Ma Z
Zhonghua Wai Ke Za Zhi; 2004 May; 42(9):536-9. PubMed ID: 15196366
[TBL] [Abstract][Full Text] [Related]
40. Concomitant polymyositis and myasthenia gravis reveal malignant thymoma. A case report and review of the literature.
Raschilas F; Mouthon L; André MH; Azorin J; Couvelard A; Guillevin L
Ann Med Interne (Paris); 1999 Sep; 150(5):370-3. PubMed ID: 10544746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
